Taries Tablet (Bepotastine Salicylate)

Adult dose

Usually, adults are administered 1 tablet (containing 7.11mg of bepotastine) orally twice daily.

This medication should not be used by patients who are hypersensitive to any of its components. Additionally, it contains lactose; therefore, it should not be administered to patients with genetic conditions such as galactose intolerance, Lapp lactose deficiency, or glucose-galactose malabsorption. Special caution is required when administering this medication to patients with renal or liver impairment, as well as to the elderly. Taking this medication may lead to neurological symptoms such as drowsiness, lethargy, headache, or dizziness. It is advisable to avoid driving or operating hazardous machinery. Gastrointestinal symptoms such as dry mouth, vomiting, and diarrhea may occur, so consultation with a physician is warranted if abnormal symptoms arise. Regular monitoring may be necessary due to potential changes in blood, liver, or kidney function test results. Any allergic reactions such as rash or swelling may occur; thus, immediate notification to healthcare professionals is needed if such reactions happen. Patients who have been on prolonged steroid treatment should gradually reduce the steroid dosage when starting this medication, and those with renal insufficiency should begin with a low dose while monitoring their condition. For patients with seasonal allergic rhinitis, it is recommended to start taking the medication prior to the onset of symptoms and continue until the symptoms cease. If no effect is observed, it is advisable not to continue long-term use. As with other antihistamines, taking this medication with alcohol can exacerbate side effects, so it should be avoided. Women who are pregnant or may become pregnant should avoid using this medication, and it should be used cautiously after consulting a physician if absolutely necessary. Similarly, nursing mothers should avoid this medication if possible, as it could be transmitted through breast milk; in cases of necessity, it is advisable to discontinue breastfeeding. Safety in pediatric patients has not been established; therefore, it is recommended not to use this medication in children. Elderly patients should take caution due to increased drug concentration that may occur due to reduced kidney function. This medication may affect allergy tests, so discontinuation before testing is recommended. For PTP-packaged medications, they should be taken directly from the packaging, ensuring that the packaging is not swallowed. Lastly, this medication should be stored out of the reach of children, in a dry place at a temperature below 30 degrees Celsius.

• Drowsiness
• lethargy
• headache
• heaviness
• dizziness
• thirst
• dry mouth
• glossitis
• nausea
• vomiting

This medication should be kept in a tightly closed container to protect it from air and moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius. Take care not to store it in excessively hot or cold places.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle